Patent · US Active

Macrocyclic compounds for suppressing replication of hepatitis C virus

US9321809B2 · kind B2 · utility

0Cited by

0References

19Claims

0Family size

Assignee

GINKGO PHARMA CO., LTD. · CN

Inventors

Ben Li · Po Tong Ha, CN
Li CHEN
Peibing Zhai · Suzhou, CN
Tao Jiang · Hangzhou City, CN

Key dates

Filing date	Dec 5, 2012
Grant date	Apr 26, 2016
Priority date	—
Expiry date	Dec 5, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K5/06078
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound as represented by Formula (I) is provided, wherein groups are defined in the description. The compound is used as HCV protease inhibitor for treating HCV infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.